Discovery and SAR of 1,3,4-thiadiazole derivatives as potent Abl tyrosine kinase inhibitors and cytodifferentiating agents

Bioorganic & Medicinal Chemistry Letters
2008.0

Abstract

A series of substituted benzoylamino-2-[(4-benzyl)thio]-1,3,4-thiadiazoles has been discovered as potent Abl tyrosine kinase inhibitors. Molecular docking simulations on the Abl tyrosine kinase were conducted in order to rationalize the SAR of the synthesized inhibitors. The most active compound identified from the enzymatic screening (6a) showed interesting inhibitory activity on Imatinib-sensitive murine myeloid 3B clone and Bcr-Abl-independent Imatinib-resistant leukemia cells. Surprisingly, 6a was also proved to act as differentiating inducers in human promyelocytic leukemia cells (HL-60).

Knowledge Graph

Similar Paper

Discovery and SAR of 1,3,4-thiadiazole derivatives as potent Abl tyrosine kinase inhibitors and cytodifferentiating agents
Bioorganic & Medicinal Chemistry Letters 2008.0
Hybrid compounds as new Bcr/Abl inhibitors
Bioorganic & Medicinal Chemistry Letters 2011.0
Design, synthesis, and biological activity of 4-(imidazo[1,2- b ]pyridazin-3-yl)-1 H -pyrazol-1-yl-phenylbenzamide derivatives as BCR–ABL kinase inhibitors
Bioorganic & Medicinal Chemistry Letters 2016.0
Discovery of New Benzothiazole-Based Inhibitors of Breakpoint Cluster Region-Abelson Kinase Including the T315I Mutant
Journal of Medicinal Chemistry 2013.0
Design and synthesis of novel 4-benzothiazole amino quinazolines Dasatinib derivatives as potential anti-tumor agents
European Journal of Medicinal Chemistry 2013.0
Structure–activity relationships of 6-(2,6-dichlorophenyl)-8-methyl-2-(phenylamino)pyrido[2,3-d]pyrimidin-7-ones: Toward selective Abl inhibitors
Bioorganic & Medicinal Chemistry Letters 2009.0
Synthesis and docking study of 2-phenylaminopyrimidine Abl tyrosine kinase inhibitors
Bioorganic & Medicinal Chemistry Letters 2011.0
Discovery of 6-phenylimidazo[2,1-b]thiazole derivatives as a new type of FLT3 inhibitors
Bioorganic & Medicinal Chemistry Letters 2015.0
Design and synthesis of 3-substituted benzamide derivatives as Bcr-Abl kinase inhibitors
Bioorganic & Medicinal Chemistry Letters 2006.0
Synthesis, biological evaluation and docking studies of 4-amino substituted 1H-pyrazolo[3,4-d]pyrimidines
European Journal of Medicinal Chemistry 2008.0